title: Cold storage of rat hepatocyte spheroids.
abstract: Cell-based therapies for liver disease rely on a high-quality supply of hepatocytes and a means for storage during transportation from site of isolation to site of usage. Unfortunately, frozen cryopreservation is associated with unacceptable loss of hepatocyte viability after thawing. The purpose of this study was to optimize conditions for cold storage of rat hepatocyte spheroids without freezing. Rat hepatocytes were isolated by a two-step perfusion method; hepatocyte spheroids were formed during 48 h of rocked culture in serum-free medium (SFM). Spheroids were then maintained in rocked culture at 37 °C (control condition) or cold stored at 4 °C for 24 or 48 h in six different cold storage solutions: SFM alone; SFM + 1 mM deferoxamine (Def); SFM + 1 μM cyclosporin A (CsA); SFM + 1 mM Def + 1 μM CsA, University of Wisconsin (UW) solution alone, UW + 1 mM Def. Performance metrics after cold storage included viability, gene expression, albumin production, and functional activity of cytochrome P450 enzymes and urea cycle proteins. We observed that cold-induced injury was reduced significantly by the addition of the iron chelator (Def) to both SFM and UW solution. Performance metrics (ammonia detoxification, albumin production) of rat hepatocyte spheroids stored in SFM + Def for 24 h were significantly increased from SFM alone and approached those in control conditions, while performance metrics after cold storage in SFM alone or cold storage for 48 h were both significantly reduced. A serum-free medium supplemented with Def allowed hepatocyte spheroids to tolerate 24 h of cold storage with less than 10% loss in viability and functionality. Further research is warranted to optimize a solution for extended cold storage of hepatocyte spheroids.
authors.affiliation: Division of Experimental Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA.
authors.forename: Hongling
authors.initials: H
authors.lastname: Liu
authors.forename: Yue
authors.initials: Y
authors.lastname: Yu
authors.forename: Jaime
authors.initials: J
authors.lastname: Glorioso
authors.forename: Shennen
authors.initials: S
authors.lastname: Mao
authors.forename: Brian
authors.initials: B
authors.lastname: Rodysil
authors.forename: Bruce P
authors.initials: BP
authors.lastname: Amiot
authors.forename: Piero
authors.initials: P
authors.lastname: Rinaldo
authors.forename: Scott L
authors.initials: SL
authors.lastname: Nyberg
mesh_terms: D000241:Adenosine / Q000494:pharmacology; D000418:Albumins / Q000235:genetics / Q000378:metabolism; D000493:Allopurinol / Q000494:pharmacology; D000641:Ammonia / Q000378:metabolism; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D003080:Cold Temperature; D016895:Culture Media, Serum-Free / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism; D003676:Deferoxamine / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology; D022781:Hepatocytes / Q000166:cytology* / Q000648:ultrastructure; D007328:Insulin / Q000494:pharmacology; D019188:Organ Preservation Solutions / Q000494:pharmacology; D011887:Raffinose / Q000494:pharmacology; D051381:Rats; D018874:Spheroids, Cellular; D013997:Time Factors; D014508:Urea / Q000378:metabolism
chemical_list: D000418:Albumins; D016895:Culture Media, Serum-Free; D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D000641:Ammonia; D016572:Cyclosporine; D014508:Urea; D003577:Cytochrome P-450 Enzyme System; D005978:Glutathione; D003676:Deferoxamine; D000241:Adenosine; D011887:Raffinose